Title |
Management options for pediatric patients who stutter: current challenges and future directions
|
---|---|
Published in |
Pediatric Health, Medicine and Therapeutics, July 2016
|
DOI | 10.2147/phmt.s77568 |
Pubmed ID | |
Authors |
Michelle A Donaghy, Kylie A Smith |
Abstract |
Stuttering is a speech disorder, with onset often occurring in the preschool years. The prevalence of stuttering in young children is much higher than that in the general population, suggesting a high rate of recovery. However, we are unable to predict which children will recover without treatment, and it is widely acknowledged that stuttering therapy during childhood provides the best safeguard against chronic stuttering. This review reports on current evidence-based stuttering treatment options for preschoolers through to adolescents. We discuss the clinical challenges associated with treating pediatric clients who stutter at different stages of development and explore potential areas of treatment research that might serve to advance current clinical practice in the future. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 57 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 28% |
Student > Bachelor | 9 | 16% |
Student > Ph. D. Student | 6 | 11% |
Researcher | 4 | 7% |
Student > Doctoral Student | 2 | 4% |
Other | 5 | 9% |
Unknown | 15 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Nursing and Health Professions | 14 | 25% |
Psychology | 8 | 14% |
Linguistics | 4 | 7% |
Arts and Humanities | 2 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Other | 8 | 14% |
Unknown | 19 | 33% |